Issue link: https://www.e-digitaleditions.com/i/1101841
6 April 2019 Tablets & Capsules wall, the researchers designed the capsule to self-orient. The MIT researchers are working with Novo Nordisk, Plainsboro, NJ, to further develop the insulin capsules and optimize the manufacturing process. The capsule product may also be used to deliver other protein drugs that normally must be injected, such as immunosuppressants used to treat rheumatoid arthritis or inflammatory bowel disease as well as nucleic acids such as DNA and RNA. markets Laboratory mixer market to reach $1.4 billion by 2023 NORTHBROOK, IL—The global laboratory mixer market is forecast to grow at a compound annual rate of 4.4 percent through 2023, reaching $1.4 billion, according to a report by Markets & Markets. Increasing research activity in the pharmaceuti- cal and biotechnology industries is expected to drive market growth. North America accounted for the largest share of the market in 2018, due to increasing demand for bio- pharmaceuticals and rising R&D expenditures by biopharmaceutical companies. Key market vendors include Thermo Fisher Scientific, Eppendorf, Corning, Scientific Industries, Bio-Rad Laboratories, Cole-Parmer, Avantor Performance Materials, IKA Works, Benchmark Scientific, REMI, Sarstedt, and Silverson Machines. Gelatin market to grow by more than 6 percent through 2023 DUBLIN, Ireland—The global gelatin market is expected to be val- ued at $3.6 billion by 2023, represent- ing a compound annual growth rate of 6.6 percent, according to a report by Research and Markets. The report states that the growing demand for functional and convenience food and beverage products, increasing applica- tion in the pharmaceutical industry, and rising demand for clean-label products will drive market growth. T h e r e p o r t i d e n t i f i e s D a r l i n g Ingredients, Gelita, Nitta Gelatin, a small needle made of compressed insulin attached to a spring held in place by a sugar disk. As the sugar disk dissolves in the stomach, the spring releases and injects the insulin needle into the stomach wall. Researchers believe that patients will not feel the injection because the stomach wall has no pain receptors. Once the tip of the needle enters the stomach wall, the insulin dissolves at a controlled rate. To ensure that the drug is injected into the stomach research Oral insulin capsule may alleviate injection-burden for diabetic patients CAMBRIDGE, MA—An MIT-led research team has developed a cap- sule product that could be used to deliver oral insulin doses, potentially providing patients with type-1 diabe- tes an alternative to daily injections. The blueberry-sized capsule contains SANITARY/USDA-ACCEPTED • PNEUMATIC CONVEYING COMPONENTS & SYSTEMS • BATCH & CONTINUOUS OPERATION MULTI-INGREDIENT HANDLING SYSTEMS • BATCH WEIGHING & SCALING SYSTEMS • UL-CONTROLS & CONTROL PACKAGES FDA-APPROVED/CERTIFIED MATERIALS OF CONSTRUCTION • 21 CFR PART 11 COMPLIANCE MOBILE VACUUM CONVEYING SYSTEMS • CIP DESIGNS • TABLET PRESS LOADING SYSTEMS • GEL CAP CONVEYORS Let us solve your pneumatic conveying challenges. Visit vac-u-max.com/pneumatic or call (800) VAC-U-MAX. More than 65 years of experience in the pharmaceutical industry. Over 10,000 powder & bulk materials handled for feeder refill, tablet press/blender loading, gel cap conveying and more. Technical expertise including FAT & SAT validation. And an airtight performance guarantee. From sanitary components to fully automated bulk material handling systems, we create pharmaceutical processing solutions designed entirely around your needs and goals. VAC-U-MAX MDL105017— Sanitary Vacuum Receiver for fine powders and granules. call (800) VAC-U-MAX. Engineered Around You. Guaranteed by Us.